GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TerrAscend Corp (TSX:TSND) » Definitions » COGS-to-Revenue

TerrAscend (TSX:TSND) COGS-to-Revenue : 0.52 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is TerrAscend COGS-to-Revenue?

TerrAscend's Cost of Goods Sold for the three months ended in Dec. 2023 was C$60.1 Mil. Its Revenue for the three months ended in Dec. 2023 was C$116.1 Mil.

TerrAscend's COGS to Revenue for the three months ended in Dec. 2023 was 0.52.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. TerrAscend's Gross Margin % for the three months ended in Dec. 2023 was 48.25%.


TerrAscend COGS-to-Revenue Historical Data

The historical data trend for TerrAscend's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TerrAscend COGS-to-Revenue Chart

TerrAscend Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial 0.96 0.35 0.42 0.59 0.50

TerrAscend Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.51 0.50 0.46 0.52

TerrAscend COGS-to-Revenue Calculation

TerrAscend's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=211.476 / 425.727
=0.50

TerrAscend's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=60.102 / 116.137
=0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TerrAscend  (TSX:TSND) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

TerrAscend's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 60.102 / 116.137
=48.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


TerrAscend COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of TerrAscend's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


TerrAscend (TSX:TSND) Business Description

Traded in Other Exchanges
Address
3610 Mavis Road, Mississauga, ON, CAN, L5C 1W2
TerrAscend Corp is a company focused on creating and delivering quality cannabis products and services that meet the evolving needs of patients. It also provides education and support programs to physicians and patients through healthcare professionals. It has one operating segment, being cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States.
Executives
Jason Wild 10% Security Holder, Director

TerrAscend (TSX:TSND) Headlines

No Headlines